↓ Skip to main content

Dove Medical Press

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Overview of attention for article published in Cancer Management and Research, July 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
7 Mendeley
Title
Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor
Published in
Cancer Management and Research, July 2020
DOI 10.2147/cmar.s253366
Pubmed ID
Authors

Jian-De Cheng, Li-Xun Chai, Zhi-Ping Zhao, Yan-Yan Hao, Shuo Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 14%
Student > Bachelor 1 14%
Lecturer 1 14%
Student > Master 1 14%
Unknown 3 43%
Readers by discipline Count As %
Medicine and Dentistry 2 29%
Computer Science 1 14%
Nursing and Health Professions 1 14%
Unknown 3 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2022.
All research outputs
#15,194,881
of 23,365,820 outputs
Outputs from Cancer Management and Research
#640
of 2,024 outputs
Outputs of similar age
#237,414
of 399,487 outputs
Outputs of similar age from Cancer Management and Research
#23
of 117 outputs
Altmetric has tracked 23,365,820 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,024 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,487 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.